Biodistribution and Radiation Dosimetry of Intraperitoneally Administered 124I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors

Conclusion: PET/CT imaging with intraperitoneally administered 124I-omburtamab enables assessment of intraperitoneal distribution and estimation of absorbed dose to peritoneal space and normal organs before therapy.

Source: Journal of Nuclear Medicine - June 30, 2022 Category: Nuclear Medicine Authors: Grkovski, M., Modak, S., Zanzonico, P. B., Carrasquillo, J. A., Larson, S. M., Humm, J. L., Pandit-Taskar, N. Tags: Clinical Investigations Source Type: research